Basel: This month, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for breast cancer were updated to recommend ribociclib (Kisqali) as a Category 1 preferred CDK4/6 inhibitor (CDK4 ...

This month, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for breast cancer were updated to recommend ribociclib (Kisqali) as a Category 1 preferred CDK4/6 inhibitor (CDK4/6i) ...

The Federal Communications Commission (FCC) has voted to transfer control of a chunk of the 4.9 GHz spectrum band to FirstNet, which operates a network for first responders that is used by AT&T. It ...

If you’re already a Spectrum TV or internet customer, it might make sense to put your smartphone on Spectrum Mobile. This is especially true nowadays as the company recently upgraded its strategy.

Recommendation comes after recent FDA approval and positive CHMP Opinion for ribociclib (Kisqali) to help reduce the risk of recurrence in EBC. (Image Credits: Pexels) The NCCN Clinical Practice ...

Field of view (FoV) is an important concept to understand whether you're a photographer or a filmmaker. When it comes to shooting, there's not only a question of what we're seeing in our image but how ...

To save this undefined to your undefined account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will ...

Spectra is a JavaScript-based hackable smartwatch based on the ESP32-S3 WiFi and Bluetooth microcontroller that aims to offer the quality of high-end consumer smartwatches with the repairability of a ...

Verizon Communications Inc., the biggest wireless carrier in the US, will buy some of US Cellular Corp.’s spectrum licenses for $1 billion as the tower operator sheds parts of its portfolio.

Oct 18 (Reuters) - United States Cellular (USM.N), opens new tab said on Friday it has agreed to sell some of its spectrum licenses to Verizon (VZ.N), opens new tab in a $1 billion deal.

Kisqali ® (ribociclib) is a selective cyclin-dependent kinase inhibitor, a class of drugs that help slow the progression of cancer by inhibiting two proteins called cyclin-dependent kinase 4 and 6 ...